Evaluation of Molecularly Imprinted Polymers as Synthetic Virus Neutralizing Antibody Mimics

Rapid development of antibody-based therapeutics are crucial to the agenda of innovative manufacturing of macromolecular therapies to combat emergent diseases. Although highly specific, antibody therapies are costly to produce. Molecularly imprinted polymers (MIPs) constitute a rapidly-evolving clas...

Descripción completa

Detalles Bibliográficos
Autores principales: Graham, Simon P., El-Sharif, Hazim F., Hussain, Sabha, Fruengel, Rieke, McLean, Rebecca K., Hawes, Philippa C., Sullivan, Mark V., Reddy, Subrayal M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542949/
https://www.ncbi.nlm.nih.gov/pubmed/31179277
http://dx.doi.org/10.3389/fbioe.2019.00115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542949/
https://www.ncbi.nlm.nih.gov/pubmed/31179277
http://dx.doi.org/10.3389/fbioe.2019.00115

Ejemplares similares